Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial

Pedro Machado, Sarah Heintzman, Thomas Blaettler et al.|The Lancet Neurology|2023

Cited by 35